Abstract
To the Editor.— In reply to the letter of Rabins et al (1983;249:353) regarding the use of anticoagulant therapy for senility, I would like to clarify some points. It is true that our studies were not "controlled," except when some patients served as their own control, when their conditions worsened when anticoagulant therapy was discontinued and improved when therapy began again. But there was a control study done in Montreal by Ratner et al 1,2 that confirms my findings of benefit from anticoagulant therapy in senility. Their study also confirms our findings as to the relative safety of anticoagulant therapy in senile persons—the Montreal group had no complications during a one-year period. In regard to the risks of falling, in 18 years, only one of our patients (and she suffered from cortical blindness and severe confusion) had serious complications from a fall, and she fell down a whole flight of
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.